Bio-valorization
Our Bio-valorization segment, which covers Tessenderlo Group’s activities in animal by-product processing, consists of PB Leiner (production, trading and sale of gelatin and collagen peptides) and Akiolis (rendering, production, trading and sale of proteins and fats).
Production locations
PB Leiner: 3 production plants in Europe (Belgium, Germany, UK), 1 in China and 3 in the Americas (US, Argentina, Brazil).
Akiolis (France): 3 production plants, 28 collection centers (C1/C2 categories), 8 production plants and collection centers (C3 category & food grade).
Core markets
Food, pharma, health & nutrition, pet food, agriculture, aqua feed, animal feed, energy, biodiesel, oleo-chemistry, and sanitary services.
Area of activity
Bio-resources, agriculture
Business drivers
- Growing demand for bio-based environmentally friendly offerings in feed, food, health & nutrition, fertilization, energy, and pharmaceutical and technical applications.
- Improved standards of living result in increased protein demand.
- Increased need for sanitary procedures to protect the food chain and the health of animals dedicated to human food.
Strategic focus
- To optimize efficiencies on existing assets.
- To focus on customer relationships and new product development.
- To vigorously focus on realizing manufacturing excellence and the improved valorization of access to raw materials.
- To increase the focus on health & nutrition(collagen peptides) and pharma.
- Valorization of fats.
- To improve the valorization of finished products in organic fertilization, pet food and aquaculture markets.
- Valorization of fats.
- To strengthen our position in our core business on sourcing markets by pushing long-term and quality-based contracts.
- To focus on customer relationships and new product development.
- To improve efficiency in existing plants and logistics.
- To focus on sanitary service for breeders, and on quality control for slaughterhouses and butchers.